Pseudomonas aeruginosa is a prevalent, opportunistic, Gram-negative bacterium that infects immunocompromised individuals, frequently causing hospital-acquired and community-acquired infections. Currently, Pseudomonas aeruginosa is one of the most widespread and fatal agents among the various causes of nosocomial infections. P. aeruginosa has been associated with increased mortality relative to Staphylococcus aureus or other Gram-negative in bloodstream infections. As few as 10-100 bacilli are capable of colonizing the intestine of critically ill or immunocompromised patients, therefore, early detection of Pseudomonas aeruginosa is particularly important. Here, we have summarized and analyzed the development of detection techniques for Pseudomonas aeruginosa over the past 50 years. We also discuss the prospects for future research on Pseudomonas aeruginosa detection methods in the hope of providing a reference for relevant studies.
Introduction
Pseudomonas aeruginosa is a widespread, opportunistic, Gramnegative bacillus that causes various clinical infections and severe infectious diseases. [1] [2] [3] Currently, it is one of the most troublesome multidrug-resistant bacterial causes of nosocomial infections; infection with Pseudomonas aeruginosa can cause long-term chronic diseases, particularly affecting immunocompromised (especially neutropenic) patients or those admitted to the intensive care unit (ICU). [4] [5] [6] In food testing, the WHO has identied Pseudomonas aeruginosa as an indicator of drinking water quality while the European Communities and the Codex Alimentarius Commission also stipulated that Pseudomonas aeruginosa should not be detected in water. 7, 8 In addition, Pseudomonas aeruginosa can cause infections at very low concentrations. Hence, early detection is critical for treating Pseudomonas aeruginosa infection. Scientists have long been committed to establishing a rapid and sensitive detection method for Pseudomonas aeruginosa. Currently, numerous modern detection approaches have been developed, such as ow cytometry (Rüger et al., 2014) , 9 immunological detection 10 and molecular biology-based detection methods.
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However, conventional culture methods are still the most commonly applied methods in clinical practice at present. Therefore, these new detection approaches still need to be further improved to achieve large-scale applications in clinical practice. Here, we review the development, advantages, and disadvantages of Pseudomonas aeruginosa detection methods.
Conventional bacterial culture methods
Conventional Pseudomonas aeruginosa detection methods are based on the biological characteristics of the bacterium under certain culture conditions, such as Gram-negative or Grampositive status, or the activities of bacterial molecules such as oxidase, acetamidase, arginine dihydrolase, and pyocyanin. In 1955, Lowbury et al. developed a selective medium for Pseudomonas aeruginosa that is supplemented with 0.03% cetrimide. The medium has very high selectivity and subsequently became one of the most common selective media for Pseudomonas aeruginosa. 12 In 1965, Brown et al. 13 developed an improved selective medium containing cetrimide, based on previous studies, and demonstrated that the Lemco-based selective medium (CTA1) promoted better pyocyanin production. Growth in selective medium with King's medium B as the base (CTA2) resulted in stronger uorescence at an incubation temperature of 42 C, while other (non-Pseudomonas aeruginosa) species did not produce uorescence at this temperature. Therefore, the CTA2 medium can serve as a diagnostic medium specic for Pseudomonas aeruginosa. Pseudomonas aeruginosa can produce ammonia as a nutrient by breaking down acetamide, an ability that is absent in other bacteria. Based on this mechanism, Szita et al. 14 (1990) developed a liquid synthetic medium in 1990 that enables higher detection selectivity, sensitivity, and speed than culture medium supplemented with cetrimide. In addition, many other researchers have investigated the feasibility of using cetrimide as an additive to identify Pseudomonas aeruginosa.
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Infection with Pseudomonas aeruginosa can cause long-term chronic diseases. Long diagnostic turnaround time can reduce patient outcomes and increase hospital costs. The automated systems promise shorter turnaround times to diagnostic results and are widely used in many clinical laboratories for identi-cation of bacterial species and antimicrobial susceptibility testing (AST). The automated systems have many advantages, such as high degree of automation with a simple operating procedure, improved specimen handling, good reproducibility and accuracy, etc. Vitek 2 (BioMérieux, France), 18 Phoenix 100 (BD Biosciences, USA) 19 and MicroScan WalkAway (Dade Behring, Inc., USA) 20 are the common automated identication systems currently used in China. The Vitek 2 is one of the earliest and most commonly used automated identication systems. 21 These automated systems not only identify Pseudomonas aeruginosa but are also capable of performing AST. Many scientists have used these instruments to analyze different sources of Pseudomonas aeruginosa and tested their identica-tion and misidentication by comparing them with conventional methods (Table 1) . For example, Bruins and his colleagues compared direct inoculation by Vitek 2 and the standard method; a total of 33 isolates of Pseudomonas aeruginosa were tested, and 78.8% were correctly identied (Bruins et al., 2004) . 22 Saiman's result showed that only 57% (108 of 189) of nonmucoid strains and 40% (24 of 60) of mucoid strains were denitively identied as Pseudomonas aeruginosa with MicroScan Autoscan. 20 In 2003, a high rate of agreement between the Phoenix and the conventional methods was observed for Pseudomonas aeruginosa identication, and the rate of agreement was 90.9%. 23 The same system showed different results in different studies, which might be due to different sample sources or experimental conditions. [25] [26] [27] [28] Although automated identication systems have been clinically used to identify a variety of microbial species, these systems have a low rate of accuracy in the identication of Pseudomonas aeruginosa. 18, 20, 24 Clinical laboratories should be aware of the problem with the automated systems in testing Pseudomonas aeruginosa and seek alternatives, validated methods for routine use.
Immunological assays
Immunological techniques utilize the highly specic binding between antibodies and antigens and facilitate qualitative or quantitative detection based on specic reactions resulted from antigen-antibody binding. Modern immunoassay techniques have achieved high-sensitivity detection and have been developed into multiple types of immunoassay methods by introducing enzyme-catalyzed reactions, uorescence, or isotope labeling as a specic measure of antigen-antibody binding.
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While reviewing the literature, we found that the main immunoassays currently applied for detecting Pseudomonas aeruginosa include enzyme-linked immunosorbent assays (ELISAs), 31 immunoblotting (IBT), 32 immunouorescence, 33 immunoelectrophoresis 34 and solid-phase radioimmunoassay, 35 which are discussed briey below.
Enzyme-linked immunosorbent assays (ELISAs)
ELISAs are based on an immunological technique that utilizes enzyme-catalyzed reactions to enhance the sensitivity of the specic antigen-antibody reaction. 30 The underlying principle is that antigens or antibodies with immunological activity are immobilized on the surface of a solid-phase carrier, and then the antigen or antibody sample to be detected is reacted with the immobilized antigen or antibody molecules, followed by the addition of enzyme-labeled antigen or antibody molecules prior to incubation. Finally, enzyme-catalyzed substrates are added for luminescence detection 31 and the enzymatic reaction plays a role in signal amplication. Currently, ELISAs has been widely applied in the detection of pathogens and food-borne bacteria. It is also considered as one of the most successful detection techniques over the past few decades. ELISAs were rst used by Ueda et al. to detect immunoglobulin M (IgM) and immunoglobulin G (IgG) in horse serum against common serological Pseudomonas aeruginosa antigens (protease and elastase). 36 With their method, horseradish peroxidase (HRP)-labeled rabbit anti-horse IgM and IgG were used as conjugated enzyme-labeled antibodies, while 5-aminosalicylic acid and H 2 O 2 were used as HRP substrates for signal amplication, thereby enabling the detection of IgM and IgG in colt and racehorses. Granstrom et al. developed a specic ELISA-based detection method against antibodies from patients infected with Pseudomonas aeruginosa, using 4 extracellular proteins as antigens: exotoxin A, elastase, alkaline protease, and phospholipase C. 37 The method was tested on samples from 39 burn patients, and the results showed that the detection of antibodies against exotoxin A and phospholipase C by ELISA could be used to monitor Pseudomonas aeruginosa infection in patients. Fomsgaard et al.
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reported the use of anti-lipopolysaccharide (LPS) antibodies to develop an ELISA method for the quantitative detection of Pseudomonas aeruginosa in cystic brosis (CF) patients with chronic infection. The results of their study showed that expression levels of anti-LPS antibodies (IgG and IgA) signi-cantly increased during the early stage of Pseudomonas aeruginosa lung infection, and they continued to increase to very high levels during later stages of infection. IgM levels increased during early infection but did not continue to increase in the later stages of infection. Fomsgaard et al. also assessed the diagnostic efficiency of this method for detecting early chronic infection with Pseudomonas aeruginosa by comparison with the immunoelectrophoresis method. Their results showed that the method targeting IgG and IgA antibodies had 86% and 89% positive predictive values, respectively, and has 98% and 97% negative predictive values, respectively. The detection rate using IgM as the target was low. Dogru et al. (2013) assessed the utility of ELISA in detecting early Pseudomonas aeruginosa infection in CF patients through comparison with culture methods. The study involved 90 CF patients with long-term follow-up. 39 The results showed that the ELISA method had a higher sensitivity in detecting anti-Pseudomonas aeruginosa antibodies, and thus, these antibodies can be used as markers for early diagnosis. Antibodies against alkaline protease showed the highest specicity, while anti-elastase antibodies showed the highest sensitivity. Although specicity is one of the major advantages of ELISA, many secreted Pseudomonas aeruginosa proteins share high homology with those of other bacteria, raising the possibility of false-positive detection. For example, Beutin et al. (1996) reported that toxins from Pseudomonas aeruginosa could induce false-positive results when assaying for Shiga-like cytotoxins, using a commercial ELISA kit. successfully detected Zika virus (ZIKV) in 1084 blood donors from Cameroon by using the EuroImmun anti-NS1 IgG ELISA detection kit. Thus, despite the specicity issue, ELISA is an important technique which has been widely used for the detection of pathogens.
Enzyme-linked immunoelectrotransfer blots (IBTs)
IBTs, also known as enzyme-linked immunoelectrotransfer blots, are immunoassays involving the integration of gel electrophoresis and immunohistochemistry. 43 IBTs involve the separation of protein samples by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) and transfer to a nitrocellulose membrane as the solid-phase carrier, using electric transfer system. 44 Subsequently, specic antibodies and enzyme-labeled antibodies are added successively, and nally, an enzyme-catalyzed substrate is added to produce a colored or luminescent product for detection purposes.
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This method integrates the high resolution of SDS-PAGE and high specicity of immunoassays; therefore, it is very suitable for the highly sensitive detection of target proteins among different complexes (Hamid et (1992) 58 established a direct immunouorescent antibody-staining method for detecting Pseudomonas aeruginosa in sputum samples using serum-specic monoclonal antibodies, in order to assess the status of pulmonary infection. The results showed that this method had a detection limit of 10 colony-forming units (CFU) per mL and could be completed within 3 h. However, the greatest drawback of immunouorescence methods is a low signal-to-noise ratio, which may lower its detection specicity. veried that immunouorescence assay was signicantly more sensitive than microscopy of iodome-stained concentrates using either formol-ethylacetate assay or salt-sugar otation.
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The developed immunoassays for Pseudomonas aeruginosa also include convective immunoelectrophoresis, which was developed by Wagner et al. 34 and solid-phase radioimmunoassay, established by Kohler et al. 35 These immunoassays have provided abundant approaches for the highly sensitive detection of Pseudomonas aeruginosa.
Molecular biology assays
Alongside the development of polymerase chain reaction (PCR) in the 1980s and the continuous progression of molecular biology methods, 61 scientists have established numerous effective molecular biology assays that have been widely applied for detecting pathogens and have provided a technical basis for epidemiological investigations, 62 pathogen-specic detection, 63 and pathogen genotyping. 64 With the development of molecular biology techniques, molecular biology-based methods for rapidly detecting Pseudomonas aeruginosa have also developed rapidly. 65, 66 Here, we summarize the development of molecular biology-based Pseudomonas aeruginosa assays.
Conventional PCR methods
The PCR technique is one of the most important inventions over the past 3 decades. In recent years, PCR-based assays for Pseudomonas aeruginosa also have developed progressively. Kingsford et al. 65 established a PCR detection method for Pseudomonas aeruginosa that specically targets the 16S rRNA gene. The method allows the detection of 1 pg chromosomal DNA or 1 Â 10 5 CFU mL À1 of Pseudomonas aeruginosa. Detection sensitivity can be increased up to 1 fg chromosomal DNA or 10 CFU mL À1 if detection is based on the use of a uorescent probe. Hummel and Unger 66 established the rst PCR method that specically detected Pseudomonas aeruginosa based on the exotoxin A gene and evaluated the effectiveness of this method for rapid Pseudomonas aeruginosa detection in mechanically ventilated patients. The results showed that the PCR method targeting exotoxin A gene detected 57 positive samples out of 364 total samples, whereas the conventional culture method only detected 36 positive samples, indicating that the exotoxin A gene-based PCR method had higher sensitivity. Alongside the continuous development of PCR assays for Pseudomonas aeruginosa, an increasing number of specic genes have been discovered, such as ecfX, gyrB, algD GDP mannose, oprL, and iC. 67 Specicity is critical for the success of conventional PCR, but is also the most important cause of failure in PCR detection. Therefore, many researchers have investigated the specicity of different Pseudomonas aeruginosa genes. For example, Dev Vos et al. (1997) examined the specicity of the oprL gene in Pseudomonas aeruginosa detection. 68 Further information on the specicity of tests for Pseudomonas aeruginosa genes is presented in Table 2 . It can be seen from Table 2 that except for iC gene, which shows low specicity, all of the other genes have very high specicity, especially the ecfX and gyrB genes, whose detection was not associated with false positive or false negative results.
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Conventional PCR was utilized widely for its developed procedure to obtain consequence of reliability and stability. Recently, PCR-based assays for clinical diagnosis and ensuring food safety have been developed progressively. For instance, Bobbi et al. (2016) detected routine clinical diagnostic specimens from patients in the USA with PCR through targeting the oppA1 gene of B burgdorferi sensu lato and identied positive specimens. 77 The combined use of conventional PCR, magnetic particles and chemiluminescence technology for the development of efficient biosensors for clinical purpose is an emerging trend. Highly sensitive and rapid detection of Pseudomonas aeruginosa was achieved using conventional PCR, magnetic particles (MNPs), and chemiluminescence technology.
78, 79 The results showed that Pseudomonas aeruginosa was successfully detected with detection limit as low as 7. 81 Qin et al. 71 established a multiplex real-time PCR assay that simultaneously and specically detected the 16S rRNA and gyrB genes of Pseudomonas aeruginosa in CF patients, and validated their reliability and sensitivity as compared with other specic genes, such as oprI, exoA, and algD. The method enabled detection of Pseudomonas aeruginosa in CF patients within a shorter period. Motoshima et al. 74 developed a real-time PCR method using melting curve analysis (MCA), which specically targeted the gyrB gene. As shown in Fig. 1 , this method could readily distinguish Pseudomonas aeruginosa from other bacteria. Comparison between the performance of the real-time PCR method and the Vitek detection system, using 224 Gram-negative bacterial samples, conrmed that this method could accurately distinguish Pseudomonas aeruginosa from other Gram-negative bacteria within 3 h. A duplex real-time PCR assay was established against 2 specic genes, ecfX and gyrB, to effectively address the false-positive and false-negative issues in detecting Pseudomonas aeruginosa.
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Le Gall et al. (2013) 82 demonstrated that multiplex real-time PCR could effectively solve the contradiction between sensitivity and specicity by analyzing the specicity and sensitivity of different genes, in addition to enabling detection of Pseudomonas aeruginosa from a mixed bacterial sample. Real-Time uorescence-based PCR was also a highly sensitive, powerfully rapid, widely useful and prospectively detected tool in respiratory tract infections and pneumonia leading pathogen. Naoyuki et al.
(2015) tested diagnostic sensitivity of immunochromatographic assay which was a rapid antigen kit for detection of Mycoplasma pneumonia, and compared with real-time PCR as gold standard. 83 Idrissa et al. 
Multiplex PCR
The main advantage of multiplex PCR is its ability to simultaneously amplify multiple PCR products in a single reaction, thereby enabling multiplex detection and signicantly reducing the detection cost and time requirements.
88 Microorganisminduced diseases are usually complicated with infections by multiple pathogens, for instance, bacteria can easily enrich and grow on the walls of catheters in patients with mechanical ventilation and renal intubation, leading to mixed infections with multiple bacteria, but a singleplex PCR assay cannot be used to simultaneously detect multiple bacterial species. 89, 90 Several studies have been conducted to establish multiplex PCR assays that include Pseudomonas aeruginosa. De Vos et al. 68 simultaneously detected Pseudomonas uorescens and Pseudomonas aeruginosa in clinical samples using a duplex PCR assay. This method had 100% sensitivity and 74% specicity, with a detection limit of 10 2 cells per mL in skin biopsy specimens from patients with burns and sputum samples from CF patients. 92 reported development of a multiplex PCR method that differentiated Liverpool epidemic strain (LES), Midlands1 (Mid1) strain, and Manchester epidemic strain (MES) with 100% specicity and sensitivity. Thong et al. developed a multiplex PCR assay that simultaneously detected methicillin-resistant Staphylococcus aureus (MRSA), Acinetobacter baumanni, Escherichia coli, Klebsiella pneumonia, and Pseudomonas aeruginosa. 93 They also optimized the PCR conditions to ensure the specicity of amplication and conrmed that this method had 100% accuracy for both positive and negative samples by testing it with 50 culture samples. To better guarantee the detection specicity, Salman et al. (2013) developed a multiplex PCR assay for simultaneous amplication of 4 specic genes: gyrB, 16s rRNA, oprL, and ETA. 94 Aghamollaei et al. (2015) developed a highly specic and sensitive method to detect Pseudomonas aeruginosa based on triplex PCR that amplies the lasI, lasR, and gyrB genes. 95 These methods could improve the specicity, but are inconvenient and have a relatively high cost in clinical applications. In 2017, Jiang et al. developed a combination of multiplex polymerase chain reaction (PCR) and capillary electrophoresis (MPCE) assay to detect thirteen bacterial pathogens responsible for lower respiratory tract infections. The result showed that the specicity and sensitivity for Pseudomonas aeruginosa were 100%. 96 Multiplex PCR was a widely useful tool for detection of respiratory pathogens and transmitted infection in clinical specimens as well. Tayoun et al. (2015) described a highly sensitive, rapid and affordable sample-to-answer multiplex PCR assay for simultaneous detection of Trichomonas vaginalis, Nesserria gonorrhoeae, and Chamydia trachomatis resulting in sexually transmitted infections (STIs). 
Isothermal amplication techniques
Isothermal amplication techniques have overcome the shortcomings of conventional PCR methods, which require thermocycling for amplication. Isothermal amplication enables the rapid amplication of nucleic acid molecules at a constant temperature, which has not only reduced the equipment demand, but also has a higher sensitivity. 98 Some recent studies have reported use of the loop-mediated isothermal amplica-tion (LAMP) technique to detect Pseudomonas aeruginosa. Goto et al. developed a LAMP assay based on a hydroxynaphthol blue (HNB) colorimetric assay (Fig. 2) , which targeted the oprL gene of Pseudomonas aeruginosa specically. The results showed that the LAMP assay had 100% specicity for the serogroup with a >10-fold greater sensitivity than conventional PCR. It could detect 130 CFU per 0.1 g of mouse feces or 3.25 CFU per reaction. In addition, performing the assay only required 2 h from DNA extraction to detection. 99 Moreover, this technique was also used to detect other organisms. For example, Liu et al.
(2017) described a sensitive, reliable LAMP method to detect Neisseria gonorrhoeae porA pseudogene, and their results showed that the sensitivity and specicity of the LAMP assay were 94.7 and 85.7%, related to traditional culture, respectively. 
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Søgaard and his colleagues evaluated the feasibility of using FISH with PNA probes to detect E. coli and Pseudomonas aeruginosa in clinical blood cultures. 103 The results showed that the method had 94.1% sensitivity and 99% specicity in detecting Pseudomonas aeruginosa. Peleg et al. developed a multiplex PNA FISH technique for the simultaneous detection of Acinetobacter and Pseudomonas aeruginosa, using dual-color uorescence, which could detect the target bacteria in a mixture consisting of 10 different bacterial species. 104 The technique was tested with 60 clinical samples, and the results showed that its sensitivity and specicity for detecting Pseudomonas aeruginosa were 100% and 95%, respectively. Although this method is very simple, it still involves a culture period for enrichment to aid the detection of Pseudomonas aeruginosa during early infection.
Aptamer-based in situ detection methods
Aptamers, also known as "articial antibodies," are short nucleic acid or peptide sequences capable of binding to a target molecule with high specicity and affinity (Ruff et al., 2012) .
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Aptamers have several advantages over antibodies, such as easy production, easy storage, easy modication, and low cost. In addition, aptamers exhibit greater affinity and specicity for targets. Therefore, aptamers have been widely applied for detecting pathogens in recent years.
106,107 Wang et al. (2011) selected a bacteria-targeting ssDNA aptamer that specically bound Pseudomonas aeruginosa and utilized its specic binding capacity to develop a rapid FISH method for detecting Pseudomonas aeruginosa (Fig. 3) . The results showed that the method had excellent specicity, and the entire detection process took 1.5-2 h. Hence, the method can potentially facilitate clinical Pseudomonas aeruginosa detection. 109 The principle of the method is to rst amplify the digoxin-labeled PCR product, which is then hybridized with a biotinylated probe. The resulting hybridization product is immobilized in a microwell plate via a biotin-streptavidin coupling system, followed by incubation with an antidigoxigenin peroxidase conjugate. Finally, the substrate molecule, 2,2-azino-di-3-ethylbenzithiazoline sulfonate, is added to enable detection. Using this method, the authors correctly identied 73 positive samples and 42 negative samples with 100% specicity and sensitivity. The method could shorten the blood culture time from 2-3 days to 6-8 h. Furthermore, other pathogens were also detected using this technique. For example, Medeiros et al. (2017) reported that kDNA PCR-ELISA exhibited satisfactory precision for detection of Leishmania infantum in 14 peripheral blood samples from immunocompetent patients. 
Electrochemical assays
Electrochemical analysis is a rapid and sensitive analytical method involving a compact device that enables qualitative and quantitative detection, using the electrochemical properties of materials. 111 Liu et al. (2011) designed an electrochemical DNA biosensor based on stem-loop-structured probes to detect Pseudomonas aeruginosa. 112 The principle of this method entails opening of the stem-loop aer hybridization, so that the biotin molecule on the probe can bind streptavidin-labeled horseradish peroxidase (SA-HRP) in solution, aer which HRP catalyzes the production of an electrochemical signal. Sensitivity test results showed that the method could be used to detect 16S rRNA at a concentration as low as 0.012 pg mL À1 , with a linear relationship between 0.3-600 pg mL À1 . reported a disposable carbon electrode sensor that could directly detect pyocyanin production by Pseudomonas aeruginosa in samples. 113 The electrochemical detection of Pseudomonas aeruginosa pyocyanin in samples could be completed within 5 min, and the entire procedure does not require samplepreparation and -isolation steps. Furthermore, the method has exhibited excellent sensitivity and specicity (Fig. 4) . In the same year, Sismaet and colleagues improved the sensitivity of square wave voltammetry (SWV) in analyzing pyocyanin production by supplementing the culture with tyrosine and valine as positive regulators of pyocyanin. 114 Sensitive detection of quorum sensing can potentially enable early detection of Pseudomonas aeruginosa and facilitate early medical intervention. Sensitive detection of quorum sensing (QS) molecules has the potential for early identication of Pseudomonas aeruginosa and, thereby, facilitating early medical intervention. Shang et al.
(2014) developed a 1-step method to prepare thiazole termed IQS, which is a recently isolated cell-cell communication molecule, and established a highly sensitive method for detecting this molecule using boron-doped diamond and glassy carbon electrodes by cyclic voltammetry and amperometry. 115 Certainly, electrochemical technique was widely acceptable and popular in detection of Pseudomonas aeruginosa and other microoragnisms, due to its preponderant feature. For example, Maciej et al. (2015) devised a selective electrochemical sensing for human serum albumin (HSA) determination using semicovalent imprinting, and established an excellent selectivity to the myoglobin and cytochrome c interferences.
116 Soa et al. (2017) reported an electrochemical aptasensor for detection of human osteopontin (OPN), a potenrial breast cancer biomarker, by using a DNA aptamer selected by SELEX. Their results showed that the aptasensor and the standard ELISA methods quantied similar OPN levels. 117 
MALDI-TOF MS assays
Matrix-assisted laser desorption/ionisation time of ight mass spectrometry (MALDI-TOF MS) is a new type of so ionization mass spectrometry, which is used to map the protein spectrum of microorganisms. 118 The mass spectrometry data of clinical microorganisms are compared with the standard protein database of known microorganisms to achieve the purpose of identication. 119 Because of its rapid, accurate, sensitive, automated and high throughput, MALDI-TOF MS has become an efficient microbial rapid identication technology used in clinical diagnosis, 120 environmental monitoring 121 and microbiological classication studies.
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Some researchers have applied this technique to the identication of Pseudomonas aeruginosa. Imperi et al. (2009) report a detailed description of the periplasmic proteome of the wild-type Pseudomonas aeruginosa strain PAO1 by 2-DE and MALDI-TOF/TOF analysis. 123 In 2012, a rapid detection and identication method for Pseudomonas aeruginosa by MALDI-TOF MS was established. 124 It was observed that the results of MALDI-TOF MS for the detection of Pseudomonas aeruginosa were consistent with that of automated identication systems Phoenix (BD Biosciences, USA). Recently, MALDI-TOF MS was used to accurately and quickly identify the ve highrisk clones of Pseudomonas aeruginosa sequence type 111 (ST111), ST175, ST235, ST253, and ST395. 125 More oen, this technique was used in Pseudomonas aeruginosa drug resistance analysis such as carbapenemase Johansson et al., 2014; Hrabak, 2015) .
126-128 MALDI-TOF MS represents an innovative technology and has a very good application prospects in the identication of Pseudomonas aeruginosa.
MALDI-TOF has been developed for identication of clinical pathogens. In fact, in addition to Pseudomonas aeruginosa, many other pathogens were detected using this technique. reported that MALDI-TOF MS was a cheap, reliable, sensitive and fast detection tool in mayy and sh species identication and sex determination in bleak (Alburnus alburnus).
Summary and prospect
Pseudomonas aeruginosa is a prevalent, opportunistic, Gramnegative bacterium that commonly infects immunocompromised individuals; thus, many cases of hospital-acquired and community-acquired infections are caused by Pseudomonas aeruginosa. P. aeruginosa has been associated with increased mortality relative to Staphylococcus aureus or other Gram-negative in bloodstream infections. 131 Previous ndings have shown that as few as 10-100 bacilli are capable of colonizing the intestine of critically ill or immunocompromised patients. 132 Therefore, early detection of Pseudomonas aeruginosa is particularly important. At present, culturing bacteria remains the most commonly applied method for detecting Pseudomonas aeruginosa in hospitals, but this method is time-consuming and susceptible to inconsistent results due to sample contamination. In addition, this method has low sensitivity. To address these issues, researchers have developed various assays, each with their own advantages and disadvantages. These methods may be limited by low stability and repeatability with regard to clinical applications, and most importantly, the risk of sample contamination remains unresolved. The developmental trend shows that direct detection of Pseudomonas aeruginosa in clinical samples will shorten diagnostic turnaround time and reduce the risk of contamination. In addition, the development of fully enclosed automatic detection techniques likely represents a primary direction of future developments.
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